The Department of Health and Human Services (HHS) announced this week it is beginning a "coordinated wind-down" of federally funded mRNA vaccine development.
This includes terminating awards and contracts with pharmaceutical companies and universities and canceling 22 investment projects worth nearly $500 million. While some final-stage contracts will be allowed to be completed, no new mRNA-based projects will be initiated, the HHS said.
Read more: https://abcnews.visitlink.me/_pL6QQ
ကြိုက်တယ်။
မှတ်ချက်
မျှဝေပါ။
